![Ruth Greferath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ruth Greferath
Career history of Ruth Greferath
Former positions of Ruth Greferath
Companies | Position | Start | End |
---|---|---|---|
AC IMMUNE SA | Founder | 13/02/2003 | - |
NormOxys, Inc.
![]() NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Founder | 03/08/2009 | - |
Corporate Officer/Principal | 31/07/2009 | - |
Training of Ruth Greferath
Yeshiva University | Doctorate Degree |
Statistics
International
United States | 3 |
Switzerland | 2 |
Operational
Founder | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Private companies | 1 |
---|---|
NormOxys, Inc.
![]() NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
- Stock Market
- Insiders
- Ruth Greferath
- Experience